表5D-0120與其他部分URAT1抑制劑療效比較-行業數據

表5D-0120與其他部分URAT1抑制劑療效比較
圖片屬性
圖片格式:PNG 圖片大?。?04KB 圖片尺寸:2306*1229
同報告圖片
 / 5
表5D-0120與其他部分URAT1抑制劑療效比較_第1頁
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
表5D-0120與其他部分URAT1抑制劑療效比較_第2頁
表5D-0120與其他部分URAT1抑制劑療效比較_第3頁
表5D-0120與其他部分URAT1抑制劑療效比較_第4頁
表5D-0120與其他部分URAT1抑制劑療效比較_第5頁
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
表5D-0120與其他部分URAT1抑制劑療效比較_第6頁
所屬報告: 益方生物-公司研究報告-立足中國具有全球視野的創新藥企業-250121(25頁).pdf
打包全文圖表

相關數據

最新數據

客服
商務合作
小程序
服務號
折疊
午夜网日韩中文字幕,日韩Av中文字幕久久,亚洲中文字幕在线一区二区,最新中文字幕在线视频网站